Our partners bring rich experience in investment, corporate venture capital, mobile, information technology, and financial industry. Advisory board provides expertise on the matters related to the intersection of medicine, academic research, technology transfer, biotechnology and business. The team is focused on sourcing innovative medical technologies under development, and uses experts from academia, hospitals, and healthcare companies.
The partners have good connections with emerging markets (Europe, Israel, Russia, Africa) and are well positioned to bring new innovative technologies to these markets, help portfolio companies with distribution networks on those markets, foster innovations and scientific cooperation.
Co-founder and Managing Partner
donna @ okmcapital.com
Ms Cordner has deep and varied experience across finance, strategy, technology, operations and social entrepreneurship globally. Ms Cordner’s strong leadership of global organizations producing results is coincident with dedication and passion toward social responsibility and long-term impacts.
In addition to her responsibilities at OKM, Ms Cordner also serves as an independent director and Chairman of the Audit Committee for Carlsberg Group, the fourth largest brewery group in the world.
Ms Cordner served as CEO of HelpAge USA, a leading NGO raising awareness on issues related to aging and ensuring older people throughout the world have access to opportunities and services. Ms Cordner served as an independent Director for Millicom International Cellular operator with US$ 4.5B in sales and operations across Latin America, Africa and formerly Asia. Between 2000-2003 Ms Cordner was Global Head of Telecom/Media Structured Finance at Citigroup/Salomon Smith Barney where she was responsible for a team of 40 professionals and a portfolio in excess of $2 billion. As Regional Head of Telecom and Media at Société Générale Ms Cordner was awarded Advisor of the Year in 1999. Ms Cordner was also the Global Head of Telecom at ABN AMRO managing a portfolio in excess of $14 billion and 250 worldwide professionals covering a wide variety of startups, structured and corporate companies.
Co-founder and Managing Partner
katerina @ okmcapital.com
Katerina is a strategic business development, mergers and acquisitions, and finance professional with extensive background in mobile technology industry. Starting her career in corporate finance and investment portfolio management, she moved to manage wireless technology and business expansion strategies for multinational corporations. Katerina led mergers and acquisitions, corporate venture capital and joint venture start-ups, achieving spectacular growth of companies’ market presence in the Eastern European countries. During 2010-2012 Katerina worked for VimpelCom, a NASDAQ-listed multinational telecom operator with US$ 23bn in sales and operations in Russia, CIS, Europe, Asia, Africa and Canada. Before that she worked for a Swedish mobile telecom operator Tele2, and for a multinational telecom operator Millicom International Cellular.
Katerina lived and worked in geographies as diverse as Siberia, Moscow, Western Europe, and the US. The entrepreneurial spirit has guided her to create, launch, and manage numbers of new initiatives inside big organizations. Katerina’s recent journey to the MIT innovation ecosystem and graduation from Sloan School of Management has inspired her to support the growing application of mobile and wireless technologies in the healthcare industry. Katerina currently serves as a mentor at two startup accelerators based in Boston: MassChallenge and StartUp Access.
Co-founder and Managing Partner
mindaugas @ okmcapital.com
Mindaugas thinks big and loves to move fast when he sees potential investment opportunities. In his early career he worked on financing solutions for private companies and later moved to risk management and modeling. He has a track record in corporate restructuring and portfolio risk management. As a consultant, Mindaugas has had a chance to travel internationally and develop an understanding about the needs of emerging markets. Mindaugas graduated from MIT Sloan School of Management, is zealous about new technologies and healthcare. He thinks that smart healthcare technologies need smart financial technologies to generate superior returns to investors and solve healthcare problems. A native of Lithuania, he was an active contributor in Delfi, a leading news and analysis website in Lithuania, is a member of System Dynamics Society and passionate about MIT CancerX initiative.
Co-founder and Managing Partner
oleg @ okmcapital.com
Oleg is known as an innovative thinker able to start and scale businesses in industries ranging from clear water bottling to information technology. He has a distinguished track record in the Information Technology space, winning partner of the year awards from CISCO, and being ranked among TOP-30 managers in the TOP-1000 rating of Russian managers, category: Information Technologies (“Russian Managers Association” and “Kommersant”, 2009). Oleg is a co-founder and CEO of CTI, a technology company ranked among “Technology Fast 500 EMEA Ranking” by Deloitte. Oleg is fast in spotting emerging trends in application of information technologies across a broad spectrum of industries, and in putting new ideas into successful commercialization.
Karsten is a life science professional with international experience in management consulting, Research & Development, and entrepreneurship in the Biotech and Semiconductor Industries. Proven track record in commercialization of academic ideas into viable businesses. Karsten is a Co-founder of Cambridge based TissueVision Inc., a leading edge provider of pre-clinical tissue imaging platforms and services. He was a post-doctoral researcher at the Department of Biological Engineering at MIT and holds a Ph.D. in Physics from the Max-Planck-Institute for Biophysical Chemistry and an MBA from MIT Sloan School of Management. Karsten advises OKM Capital on matters related to the intersection of medicine, academic research and business.
Medical Device Advisor
Farzad is a senior executive with a broad experience in the medical device industry and a deep understanding of U.S. and international regulations applicable to medical devices. Farzad is the Chief Operating Officer of GeNO LLC, a biopharmaceutical firm that is developing inhaled nitric oxide (NO) products for treatment of a variety of pulmonary and cardiac diseases. Previously Farzad served as the COO-U.S. for Levitronix LLC, a privately-held Class III medical device manufacturer. Prior to Levitronix, Farzad held management positions in the quality assurance, regulatory affairs, research and development, program management, and marketing at Boston Scientific, Thermo Cardiosystems, Medtronic and CR Bard. Farzad received a Masters of Education in Management from the Cambridge College and an MBA from the MIT Sloan School of Management. Farzad advises OKM Capital on matters related to the medical device regulatory landscape, regulatory and operations due diligence, and market readiness.
Technology Adoption at Hospitals
Anthony is a senior executive with a diverse global career spanning 23 years as a COO, CFO, Business and transformation Leader in Healthcare, Financial Services, Management Consulting and the Military. Prior to coming to Boston, Anthony held senior global roles in such institutions as Deutsche Bank and GE Capital, primarily based in the Asia Pacific region.
Anthony is currently the Head of Strategic Business Transformation and Innovation at Boston Children’s Hospital. Prior to Boston Children’s Hospital he completed the Sloan Fellows program, a year intensive MBA program for senior executives at MIT Sloan School of Management. Anthony advises OKM Capital on matters related to health data privacy and adoption of mobile health technologies in hospitals
Personalized medical technologies
Parag Mallick, Ph.D., Professor at Stanford University. His research spans systems biology, cancer biology, nanotechnology, micro-devices, bioinformatics and biophysics. Beyond studying fundamental disease mechanisms, his group has been pioneering novel approaches for enabling personalized and predictive medicine and has led to the creation of several successful companies. Parag has extensive expertise working with diverse venture funds on scientific evaluation of potential investments. Recently, has been working with a number of groups to develop new funding vehicles to bring innovative, world changing advances to market. Parag advises OKM on personalized and predictive medical technologies, including imaging, big data analytics, genetics and cancer research. His website:
Buff, MD, Ph.D.
Technology Transfer Advisor
Dr. Eugene Buff is a Registered Technology Transfer Professional (RTTP) and Certified Licensing Professional (CLP) with over twenty years of combined scientific, consulting and management experience. He has substantial expertise in a wide variety of industries, including healthcare, biotechnology, medical devices, consumer products, materials and chemical manufacturing.
Dr. Buff is a Founder and the Lead Consultant of Primary Care Innovation Consulting, a Co-Founder and one of the Principals of UsTech Discovery LLC. For over eight years Dr. Buff served as a Vice President at yet2.com, Inc. and lead consulting projects for yet2.com clients on both technology licensing and technology acquisitions. He has been a primary broker on several highly publicized licensing deals.
Dr. Buff advises OKM Capital on issues of Intellectual Property and Technology Transfer.